Navigation Links
CPG Implements First-Ever Agile PLM Release 9.3 at Avema Pharma Solutions
Date:11/16/2009

BOCA RATON, Fla., Nov. 16 /PRNewswire/ -- CPG has successfully implemented the first instance of Oracle's Agile Product Lifecycle Management (PLM) Release 9.3 at Avema Pharma Solutions, a division of PL Developments. Avema is an integrated single source manufacturing operation of pharmaceutical, over-the-counter (OTC), and nutritional solid-dose products based in Miami, Florida.

The new Agile system went live at Avema on September 28, 2009. "As a contract manufacturer of pharmaceuticals, Avema collaborates with our clients on the development, manufacture, and introduction of new products," said Thomas Crowe, CIO of Avema. "By implementing Agile PLM we have world-class portfolio management and product collaboration capabilities, along with flexible packaging options to meet the diverse needs of our clients. This will allow us to decrease our time to market, accelerate our market growth, and improve the service we provide to our customers."

Avema has the capacity to manufacture 8 billion dosages of pharmaceutical, OTC and nutritional solid-dose products. PL Developments offers extensive marketing services, including package design, branding, advertising, distribution, promotional materials, displays and digital media. The new system is designed to support the complete product lifecycle. CPG is now working with PLD on an enterprise-wide rollout of the Agile PLM Suite and the implementation of Oracle E-Business Suite.

The Oracle-CPG Solution

With Agile PLM in place, Avema gained efficiencies in portfolio visibility, process and schedule management, as well as content and resource management. "We implemented a single repository for Research & Development and Sales & Marketing content, made knowledge easily available across the organization and completely replaced the use of spreadsheets and databases for key functions," said Ali Safadi, Partner at CPG. Avema now has dashboards and reports th
'/>"/>

SOURCE CPG Solutions
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Patient Receives vProtect(TM) Luminal Shield in First-Ever Vulnerable Plaque Clinical Trial
2. Eularis Releases First-Ever Study on ROI of Pre-Launch Named Patient Programmes
3. Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health, First-Ever Leading Calcium Supplement to Help Support Bone AND Heart Health
4. Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch
5. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
6. Tourtellotte Solutions Blazes Trail with New Release of Clinical Trial Supply Chain Simulator
7. CEL-SCI Corporation Releases Letter to Shareholders
8. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
9. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
10. ASCO and ASH Release Updated Guideline on the Use of Chemotherapy-Related Anemia Treatments in Cancer Patients
11. New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , May 21, 2013 Abaxis, Inc. ... analysis systems, announced today that Martin Mulroy ... the Stifel Annual Dental & Veterinary Conference on Wednesday, ... will be held at Le Parker Meridien Hotel in ... About Abaxis Abaxis develops, manufactures, markets and ...
(Date:5/21/2013)... , May 21, 2013 ... report is available in its catalogue: ... and Reimbursement Scenario for Medical Devices in ...   Changing Regulatory ... the US Market   ...
(Date:5/21/2013)... 21, 2013 STAAR Surgical Company (NASDAQ: ... of minimally invasive ophthalmic products, today announced that it ... the Company,s recent financial results and business developments with ... present at the 38 th Annual Deutsche Bank ... at the Westin Waterfront Hotel on Wednesday, May 29, ...
Breaking Medicine Technology:Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 3Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 4STAAR Surgical To Present At Upcoming Investor Conferences 2
... VIEW, Calif., June 23 Alexza,Pharmaceuticals, Inc. (Nasdaq: ... present,results of its Phase 2a clinical trial of ... at the 50th Annual Scientific Meeting of,the American ... Boston,Copley Place in Boston, MA. The oral platform ...
... data from,PAREXEL International Corporation (Nasdaq: PRXL ), ... new,industry-sponsored clinical trial initiations, or starts, surged another ... analysis shows that the,biopharmaceutical industry submitted 662 commercial ... clinical studies for drugs in,2007, up from the ...
Cached Medicine Technology:Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting 2PAREXEL Data Reveal A Record High Number of Clinical Trials Initiated 2PAREXEL Data Reveal A Record High Number of Clinical Trials Initiated 3PAREXEL Data Reveal A Record High Number of Clinical Trials Initiated 4PAREXEL Data Reveal A Record High Number of Clinical Trials Initiated 5
(Date:5/21/2013)... Diversity Focus, a non-profit organization striving to improve the ... Creative Corridor region, is releasing results for its 2013 ... Thursday, May 23rd at 10:30 a.m. The survey ... , The survey is a critical component to the ... nurture and retain people of diverse backgrounds, cultures and ...
(Date:5/21/2013)... AURORA, Colo. (May 21, 2013) A paper recently ... and co-written by physicians and scientists at the ... important genetic risk factor for pulmonary fibrosis can be ... lung disease. , Researchers looked at a fairly common ... is a component of the mucous produced by the ...
(Date:5/21/2013)... and technological research So Paulo Research Foundation, FAPESP, based ... estimated in US$ 680 million to support 17 Research, ... up to eleven years, subject to continuation reviews on ... the 17 RIDCs will come from FAPESP and the ... infrastructure). Host institutions will participate in a portion of ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Today, Zane ... HSA and FSA accounts. Zane Benefits, which provides ... benefits, is the leader in defined contribution ... arrangements . , According to Zane Benefits’ website, the ... was signed into law in 2010 and impacts many ...
(Date:5/21/2013)... 2013 While North Carolina is synonymous ... travel guides. Brunswick Plantation & Golf Resort is synonymous ... access to 27 holes of "Top10" championship golf. ... Carolina, knowing the Top 10 from an ... the overwhelming task of selecting the course to play. ...
Breaking Medicine News(10 mins):Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2Health News:Researchers find genetic risk factor for pulmonary fibrosis 2Health News:Research at the cutting edge of knowledge 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 3Health News:Brunswick Plantation & Golf Resort Named in Top 10 Golf Resorts in North Carolina 2
... for diabetes and heart disease, such as high blood ... risk typical of obesity, but they represent only a ... long-term study. The results will be presented Saturday at ... "Some obese persons have a normal cardiovascular risk ...
... ... product line. , ... Germantown, WI (PRWEB) June 19, 2010 -- Ellsworth Adhesives announced today it ... Rapid Seal® line offers high-performance, flexible, chemical resistant sealants that are designed for a ...
... June 2010: Achieving disease remission in patients with ... of socio-economic importance including work productivity and quality ... EULAR 2010, the Annual Congress of the European ... Austrian findings are reported in addition to improvements ...
... ... dedication among healthcare professionals. This awards program salutes the individual health care ... the patients and family members they serve in every sector of the ... Press Club in Washington, D.C., on October 4, where the award winners ...
... for many with low risk disease, researchers find , ... prostate cancer that has a low risk of progression, ... a suitable treatment option, according to a large-scale study ... to treat localized prostate cancer is controversial because, especially ...
... ... Gynecologic Oncologist Mildred Ridgway, MD is now performing a new procedure at Baptist Medical ... Removing uterine fibroids is referred to as a myomectomy, or fibroidectomy. , ... Jackson, MS (Vocus) June 18, ...
Cached Medicine News:Health News:Certain obese people are not at high risk of heart disease, diabetes 2Health News:Ellsworth Adhesives Is Adding PRC Rapid Seal Product Line Offering 2Health News:Targeting disease remission has socio-economic benefits over low disease activity 2Health News:Targeting disease remission has socio-economic benefits over low disease activity 3Health News:Dorland Health People Awards Accepting Entries through Friday, June 25, 2010 2Health News:'Watchful Waiting' Often Best Strategy for Slow-Moving Prostate Cancer 2Health News:GYN Oncologist Uses da Vinci Surgical Robot to Preserve Fertility 2
For Dermolipectomy or Lipoplasty of upper arms, Lipoplasty of anterior and lateral axillary folds/rolls...
Short-Sleeve Bolero for targeted compression in the upper arms, back and shoulder areas. Plush-shielded hook and eye front closure for comfort and convenient application....
Fully lined with cotton material for extra softness against patients skin. The 3 single adjustable soft Velcro® band provides,downward pressure preventing implants from moving upward or to the s...
Provides gentle compression above and below implants...
Medicine Products: